Login / Signup

Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial.

Marina V ShestakovaBoris KvasnikovEkaterina ErinaElena IsachenkoAlexander Andreevnull null
Published in: BMJ open diabetes research & care (2023)
ISRCTN39549850.
Keyphrases
  • phase iii
  • placebo controlled
  • double blind
  • clinical trial
  • phase ii
  • open label
  • study protocol
  • phase ii study
  • african american
  • randomized controlled trial
  • radiation therapy
  • rectal cancer